66 related articles for article (PubMed ID: 18616907)
1. [Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line].
Gao XN; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):668-71. PubMed ID: 18616907
[TBL] [Abstract][Full Text] [Related]
2. [Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].
Gao XN; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):806-10. PubMed ID: 19176033
[TBL] [Abstract][Full Text] [Related]
3. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
Gao XN; Wang LL; Lin J; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
[TBL] [Abstract][Full Text] [Related]
4. [DNA methylation regulates kir3dl1 gene expression in K562 cell line].
Gao XN; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):472-5. PubMed ID: 18549610
[TBL] [Abstract][Full Text] [Related]
5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
6. E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
Gao XN; Yu L
Biochem Biophys Res Commun; 2008 Jun; 370(3):399-403. PubMed ID: 18358829
[TBL] [Abstract][Full Text] [Related]
7. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
[TBL] [Abstract][Full Text] [Related]
9. [Killer immunoglobulin-like receptor gene genotype and expression pattern in NK-92MI and K562 cells].
Dou LP; DA WM; Liu JH; Sun JF; Zhao Y; Wang QS; Gao CJ; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):767-9. PubMed ID: 19737456
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
12. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter.
Zimmermann P; Boeuf S; Dickhut A; Boehmer S; Olek S; Richter W
Arthritis Rheum; 2008 Sep; 58(9):2743-53. PubMed ID: 18759285
[TBL] [Abstract][Full Text] [Related]
13. Demethylating treatment suppresses natural killer cell cytolytic activity.
Gao XN; Lin J; Wang LL; Yu L
Mol Immunol; 2009 Jun; 46(10):2064-70. PubMed ID: 19394699
[TBL] [Abstract][Full Text] [Related]
14. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
16. [Effect of methylation inhibitor on demethylation pattern of the PD-1 gene in promoter region and PD-1 expression in human T lymphocyte cell line].
Zhang M; Xiao X; Liang Y; Peng M; Jiang Y; Xu Y; Gong G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1163-9. PubMed ID: 22246361
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
18. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis.
Nile CJ; Read RC; Akil M; Duff GW; Wilson AG
Arthritis Rheum; 2008 Sep; 58(9):2686-93. PubMed ID: 18759290
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
